Globally, thalassaemia occurs in approximately 4 of every 10,000 births. In 2018, the Malaysian Thalassaemia Registry recorded a total of 7,984 thalassaemia patients. Although the Malaysian registry recorded a decreasing trend in thalassaemia births from 2013 to 2018, this disorder is still the most common hereditary hemoglobinopathy. This module aims to provide physicians with a comprehensive overview of the different thalassaemia phenotypes and the available treatment options.
Dr Zulaiha Muda
Consultant Paediatric Haemato-oncologist
Hospital Kuala Lumpur
• Q&A session
Who should participate:
Please watch the video before attempting the assessment questions.
Terms & Conditions:
■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points
To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.